Evidence map›Paper›PMID 35208210›Full record

ArticleMetabolites2022

Comparative Evaluation of Plasma Metabolomic Data from Multiple Laboratories.

Shin Nishiumi, Yoshihiro Izumi, Akiyoshi Hirayama, Masatomo Takahashi, Motonao Nakao, Kosuke Hata, Daisuke Saigusa, Eiji Hishinuma, Naomi Matsukawa, Suzumi M Tokuoka and 11 more

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. LC-MS-Based Analytical Strategies for Ganglioside Profiling.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  2. Article
  3. Male-specific amelioration of lipid metabolism by edible insectFood chemistry. Molecular sciences · 2025
    Article
  4. Seed Watermelon (Molecules (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 1 country.

Shin NishiumiDepartment of Omics Medicine, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya-city, Hyogo 663-8501, Japan.ORCID 0000-0003-2126-3013
Yoshihiro IzumiDivision of Metabolomics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-city, Fukuoka 812-8582, Japan.ORCID 0000-0003-4608-4652
Akiyoshi HirayamaInstitute for Advanced Biosciences, Keio University, 246-2 Mizukami, Kakuganji, Tsuruoka-city, Yamagata 997-0052, Japan.ORCID 0000-0002-0440-6820
Masatomo TakahashiDivision of Metabolomics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-city, Fukuoka 812-8582, Japan.ORCID 0000-0002-2493-2684
Motonao NakaoDivision of Metabolomics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-city, Fukuoka 812-8582, Japan.ORCID 0000-0003-0927-7762
Kosuke HataDivision of Metabolomics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-city, Fukuoka 812-8582, Japan.ORCID 0000-0002-2278-4796
Daisuke SaigusaLaboratory of Biomedical and Analytical Sciences, Faculty of Pharma-Science, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan.ORCID 0000-0001-9484-9870
Eiji HishinumaDepartment of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai-city, Miyagi 980-8573, Japan.
Naomi MatsukawaDepartment of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai-city, Miyagi 980-8573, Japan.
Suzumi M TokuokaDepartment of Lipidomics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Yoshihiro KitaDepartment of Lipidomics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Fumie HamanoDepartment of Lipidomics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Nobuyuki OkahashiDepartment of Bioinformatic Engineering, Graduate School of Information Science and Technology, Osaka University, 1-5 Yamadaoka, Suita-city, Osaka 565-0871, Japan.ORCID 0000-0001-9582-355X
Kazutaka IkedaLaboratory of Biomolecule Analysis, Department of Applied Genomics, Kazusa DNA Research Institute, 2-6-7 Kazusa-Kamatari, Kisarazu-city, Chiba 292-0818, Japan.ORCID 0000-0001-9247-4593
Hiroki NakanishiLipidome Lab Co., Ltd., 1-2 Nukazuka, Yanagida, Akita-city, Akita 010-0825, Japan.ORCID 0000-0002-5108-1598
Kosuke SaitoDivision of Medical Safety Science, National Institute of Health Sciences, 3-25-26 Tonomachi Kawasaki-ku, Kawasaki-city, Kanagawa 210-9501, Japan.ORCID 0000-0002-1035-3454
Masami Yokota HiraiRIKEN Center for Sustainable Resource Science, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama-city, Kanagawa 230-0045, Japan.ORCID 0000-0003-0802-6208
Masaru YoshidaDepartment of Food Science & Nutrition, Research Institute of Food and Nutritional Sciences, Graduate School of Human Science & Environment, University of Hyogo, 1-1-12 Shinzaikehon-cho, Himeji-city, Hyogo 670-0092, Japan.
Yoshiya OdaDepartment of Lipidomics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.ORCID 0000-0001-5680-6394
Fumio MatsudaDepartment of Bioinformatic Engineering, Graduate School of Information Science and Technology, Osaka University, 1-5 Yamadaoka, Suita-city, Osaka 565-0871, Japan.ORCID 0000-0003-1091-778X
Takeshi BambaDivision of Metabolomics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-city, Fukuoka 812-8582, Japan.ORCID 0000-0002-7442-2738
Kyushu University · JPThe University of Tokyo · JPTohoku University · JPThe University of Osaka · JPHyogo Medical University · JPKazusa DNA Research Institute · JPKeio University · JPNational Institute of Health Sciences · JPRIKEN Center for Sustainable Resource Science · JPUniversity of Hyogo · JP

Funding

the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) JPMJTR204Jthe Advanced Genome Research and Bioinformatics Study to Facilitate Medical Innovation (GRIFIN) 20 km0405209h0003the AMED-CREST 19gm0710013h0506the AMED-CREST JP21gm0910010 and JP21gm1010010the Grant-in-Aid for Scientific Research (C) 21K12676the Grant-in-Aid for Scientific Research on Innovative Areas 17H06303the JST-Mirai Program JPMJMI20G1the JST Moonshot JPMJMS2011-62the Practical Research Project for Rare/Intractable Disease 20ek0109396S0403the Tohoku Medical Megabank Project JP20km0105001 and JP20km0105002
6 · The paper itself

Abstract

In mass spectrometry-based metabolomics, the differences in the analytical results from different laboratories/machines are an issue to be considered because various types of machines are used in each laboratory. Moreover, the analytical methods are unique to each laboratory. It is important to understand the reality of inter-laboratory differences in metabolomics. Therefore, we have evaluated whether the differences in analytical methods, with the exception sample pretreatment and including metabolite extraction, are involved in the inter-laboratory differences or not. In this study, nine facilities are evaluated for inter-laboratory comparisons of metabolomic analysis. Identical dried samples prepared from human and mouse plasma are distributed to each laboratory, and the metabolites are measured without the pretreatment that is unique to each laboratory. In these measurements, hydrophilic and hydrophobic metabolites are analyzed using 11 and 7 analytical methods, respectively. The metabolomic data acquired at each laboratory are integrated, and the differences in the metabolomic data from the laboratories are evaluated. No substantial difference in the relative quantitative data (human/mouse) for a little less than 50% of the detected metabolites is observed, and the hydrophilic metabolites have fewer differences between the laboratories compared with hydrophobic metabolites. From evaluating selected quantitatively guaranteed metabolites, the proportion of metabolites without the inter-laboratory differences is observed to be slightly high. It is difficult to resolve the inter-laboratory differences in metabolomics because all laboratories cannot prepare the same analytical environments. However, the results from this study indicate that the inter-laboratory differences in metabolomic data are due to measurement and data analysis rather than sample preparation, which will facilitate the understanding of the problems in metabolomics studies involving multiple laboratories.

Indexed as

hydrophilic metabolitehydrophobic metaboliteinter-laboratory comparisonmass spectrometrymetabolomicsrelative quantification

Identifiers

PMID35208210
PMCPMC8877229
OpenAlexW4210616727

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.